Beam Therapeutics Inc.

NASDAQ: BEAM · Real-Time Price · USD
17.85
-0.39 (-2.14%)
At close: May 13, 2025, 11:08 AM

Beam Therapeutics Revenue

Beam Therapeutics reported an annual revenue of $63.52M, reflecting a -83.18% growth. For the quarter ending March 31, 2025, Beam Therapeutics generated $7.47M in revenue.
Revenue (ttm)
$63.52M
Revenue Growth
-83.18%
Price / Sales Ratio
32.14
Revenue / Employee
$161.62K
Employees
393
Market Cap
1.79B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.